NCT04926779View on ClinicalTrials.gov

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test

NACompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

May 24, 2021

Primary Completion Date

November 4, 2022

Study Completion Date

November 4, 2022

Conditions
Covid-19 Testing
Interventions
DIAGNOSTIC_TEST

Biozek Covid-19 Antigen Rapid Test (Saliva)

Self-collection of nasopharyngeal and saliva samples and self test performance - Biozek Covid-19 Antigen Rapid Test (Saliva) and Biozek Covid-19 Antigen Rapid Test (Nasopharyngeal Swab). Both procedures are supervised by trained study personnel.

Trial Locations (2)

11354

Mobile Covid Services LLC, Flushing

11968

Quality Research and Invention LLC, Southampton

All Listed Sponsors
lead

Mach-E B.V.

INDUSTRY